• Eltanexor (KPT-8602): XPO1 Inhibition for Cancer Research

  2026-04-27

  Eltanexor (KPT-8602) is a second-generation, orally bioavailable XPO1 inhibitor with proven anticancer effects across hematological and solid malignancies. Preclinical data demonstrate its superior selectivity and tolerability relative to earlier compounds. Eltanexor modulates nuclear export, disrupts oncogenic signaling, and enables mechanistic cancer research.

• Pregnenolone Carbonitrile: Applied Workflows & Troubleshooti

  2026-04-27

  Pregnenolone Carbonitrile (PCN) empowers researchers to dissect both hepatic xenobiotic metabolism and antifibrotic mechanisms, with reproducibility and sensitivity. This guide provides protocol enhancements, troubleshooting insights, and practical translation of the latest PXR research for advanced liver and renal physiology studies.

• ω-Agatoxin IVA TFA: Decoding Cardiac-Neuronal Pathways in Ne

  2026-04-26

  Explore how ω-Agatoxin IVA TFA uniquely elucidates P/Q-type channel function in cardiac vagal neurons and advances neuroprotection research. This article reveals mechanistic insights, protocol guidance, and a reference-driven perspective on neuronal calcium current recording.

• ECL Western Blotting Substrate: Technical Use and Protocol G

  2026-04-25

  ECL Western Blotting Substrate (SKU K2187) provides a sensitive, nonradioactive solution for detecting horseradish peroxidase (HRP) in immunoblotting workflows, allowing clear signal capture and repeated probing without loss of quality. This product is optimal for chemiluminescent protein detection in Western blot assays but is not suitable for applications requiring fluorescent or radioisotopic labeling.

• CCCP (carbonyl cyanide m-chlorophenyl hydrazine): Mechanism

  2026-04-24

  CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is a benchmark uncoupler of oxidative phosphorylation that disrupts the mitochondrial proton gradient, enabling precise study of mitochondrial energetics and disease models. Its mechanism, validated in vitro, underpins mitochondrial research but carries specific experimental and interpretative limits.

• Moxidectin (SKU B3611): Optimizing Antifungal Assays in the

  2026-04-24

  This article explores how Moxidectin (SKU B3611), a macrocyclic lactone anthelmintic, addresses practical experimental challenges in cell viability and antifungal synergy assays. Drawing on recent literature, we demonstrate how APExBIO’s high-purity Moxidectin enables reproducible, data-driven workflows for biomedical researchers seeking robust, cross-domain solutions.

• Antimycin A4: Advanced Mechanistic Insights for Energy Metab

  2026-04-23

  Explore the dual-action mechanism of Antimycin A4 as a potent ATP-citrate lyase inhibitor and mitochondrial research tool. This article uniquely bridges chemical innovation with practical assay strategy, offering a deeper perspective on its application for dissecting energy metabolism.

• Dorsomorphin (Compound C): Precision Control of AMPK Pathway

  2026-04-23

  Dorsomorphin (Compound C) enables selective, ATP-competitive inhibition of AMPK and BMP signaling for metabolic, autophagy, and differentiation studies. This guide explores real-world workflows, optimization strategies, and troubleshooting informed by the latest evidence and APExBIO's trusted supply.

• Angiotensin 1/2 (1-6): Benchmarks in Vascular Tone Research

  2026-04-22

  Angiotensin 1/2 (1-6), an Asp-Arg-Val-Tyr-Ile-His hexapeptide, is a validated modulator of vascular tone and a robust tool for renin-angiotensin system research. Recent findings show its direct impact on peptide-receptor interactions and its use as a precision reagent in cardiovascular and renal physiology studies.

• SC 79 Akt Activator: Protocols and Neuroprotection in Resear

  2026-04-22

  SC 79, a potent small molecule Akt activator, offers unique cytosolic activation for precise control in neuroprotection and metabolic research. This guide details optimized workflows, troubleshooting strategies, and actionable insights—turning complex Akt signaling modulation into reproducible results.

• Re-evaluating ACE Inhibitor and Aminopeptidase Selectivity i

  2026-04-21

  This article analyzes Tieku and Hooper’s comparative study on the inhibition profiles of key mammalian cell-surface aminopeptidases and ACE, revealing critical distinctions in inhibitor specificity. Findings clarify which compounds selectively target AP-A, AP-N, AP-W, or ACE, informing the design of selective peptidase inhibition protocols in cardiovascular, renal, and related disease research.

• Sulfo-NHS-Biotin in Single-Cell Platforms: Mechanistic Depth

  2026-04-21

  Explore how Sulfo-NHS-Biotin enables next-generation single-cell and high-throughput protein labeling assays. This in-depth article offers a mechanistic perspective and practical workflow insights not covered in existing guides.

• Stiripentol as a Precision LDH Inhibitor: Beyond Epilepsy Re

  2026-04-20

  Explore Stiripentol, a novel LDH inhibitor, and its advanced role in dissecting lactate metabolism and immune regulation. This article reveals unique assay insights and translational opportunities not covered by typical product reviews.

• MK 0893: Glucagon Receptor Antagonist for Advanced Diabetes

  2026-04-20

  MK 0893 is a validated glucagon receptor antagonist that enables highly selective, reproducible cAMP inhibition assays and glucose excursion studies in both cell-based and animal models. APExBIO's MK 0893 stands out for its allosteric binding specificity and robust performance in type 2 diabetes workflows.

• Saracatinib (AZD0530): Deep Mechanistic Insights for Oncolog

  2026-04-19

  Explore the advanced mechanistic underpinnings of Saracatinib (AZD0530) as a dual Src/Abl kinase inhibitor for cancer biology. This article delivers unique assay optimization guidance and integrates new insights from synaptic signaling research.

449 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page